DEBORAH MURRAY: Open Payments
NPI 1518208495 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,804 in 73 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $686 · 2025 $1,804
Food & beverage: $1,804
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $315 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $260 |
| Corcept Therapeutics | 9 | $178 |
| Janssen Pharmaceuticals, Inc | 4 | $159 |
| Axsome Therapeutics, Inc. | 6 | $137 |
| Novartis Pharmaceuticals Corporation | 5 | $118 |
| PFIZER INC. | 4 | $89 |
| Lundbeck LLC | 2 | $77 |
| Lilly USA, LLC | 3 | $71 |
| Amgen Inc. | 3 | $58 |
Products named: CAPLYTA, Korlym, SPRAVATO, Auvelity, LEQVIO, UBRELVY, VRAYLAR, REXULTI.
Industry payments across CA — which companies pay providers there.
